Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis

Zahedi, Razieh; Vardanjani, Hossein Molavi; Baneshi, Mohammad Reza; Haghdoost, Ali Akbar; Afshar, Reza Malekpour; Sarabi, Roghayeh Ershad; Tavakoli, Fatemeh; Zolala, Farzaneh

doi:10.1186/s12905-020-00903-z

Cited by 20 publications

(18 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of malignant tumours was higher in this study with 139 cases (27.5%) than in comparable studies from North Africa, the Middle East [ 23 , 24 ], Europe [ 25 , 26 ], or Iran [ 27 ]. This phenomenon can be explained by the specialization of the authors RR and AS in this field and the increased awareness of the risk population in the region.…”

Section: Discussioncontrasting

confidence: 78%

“…It could be the result of training programs for nurses and midwives started by Dr. Rauofi Rokai in 2016. Mastitis has been associated with lactation in 85.7% ( Table 2 ) of cases, most likely a cause that this rate is higher as in the neighbouring countries [ 23 – 25 , 27 , 29 , 30 ]. The reasons may be a long breast feeding time and inadequate hygiene measurements.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The Importance of Clinical Data for the Diagnosis of Breast Tumours in North Afghanistan

Stauch¹,

Fritz

Rauofi³

et al. 2021

International Journal of Breast Cancer

View full text Add to dashboard Cite

Background. This study was performed in knowledge of the increasing gap between breast disease treatment in countries with restricted resources and developed countries with increasingly sophisticated examination methods. Methods. The authors present the analysis of a breast disease register consisting of diagnostic cases from Mazar e Sharif and Herat in 2018 and 2019. The study comprises a total of 567 cases, which were presented to experts via telemedicine for final diagnosis. 62 cases (10.9%) were excluded due to inacceptable data or insufficient image quality. These data provided by daily diagnostic classification were used for the built-up of a profile for each frequent breast disease and a breast cancer register. All images and cases were seen by at least 3 independent experts. The diagnoses were made in 60% of cases by cytology of fine needle aspiration and in 40% by histological images. Results. For each entity of breast diseases (e.g., fibroadenoma), a profile of context variables was constructed allowing to assist medical decisions, as “wait and see,” elective surgery or immediate surgical intervention with R0 (complete) resection. These “profiles” could be described for fibroadenoma, mastitis, galactocele, fibrous-cystic disease, and invasive breast cancer. Conclusions. The presented preliminary data set could serve as a cost-effective basis for a North Afghan breast cancer registry, with option to extent to a national model. These preliminary data are transformed in profiles of breast diseases, which are used by the local physicians in charge of breast disease patients. Each new case can be compared by the local treating physician with the profile of all preceded cases with the same diagnosis.

show abstract

Section: Discussioncontrasting

confidence: 78%

Section: Discussionmentioning

confidence: 99%

The Importance of Clinical Data for the Diagnosis of Breast Tumours in North Afghanistan

Stauch¹,

Fritz

Rauofi³

et al. 2021

International Journal of Breast Cancer

View full text Add to dashboard Cite

show abstract

“…In line with our study, a meta-analysis in the period 2005-2019 revealed that the ASR of breast cancer had been increasing in the Eastern Mediterranean Region (EMRO). 12 The Breast cancer ASR for Asia in the present study was higher than that for EMRO. An increasing trend of breast cancer incidence rates was also noted in Hong Kong in the period 1983-2008 13 and in China during 2000-2015.…”

Section: Discussioncontrasting

confidence: 57%

Trends in the Incidence Rates of Breast and Gynecological Cancers in Asia from 1998–2012: An Ecological Study

2022

View full text Add to dashboard Cite

Background: There is limited evidence on the epidemiology and time trend analysis of incidence rates of gynecological cancer in Asia as a whole. We conducted this study to demonstrate breast and gynecological cancers incidence and trends in selected Asian populations. Method: We conducted this ecological study using cancer and population data from cancer incidence in five continents (CI5). We extracted the data of breast, uterine, cervix and ovary cancers in selected Asian populations from 1998 to 2012 from CI5plus. We used Joinpoint regression model (version 4.8.0.1) to evaluate the annual percentage change (APC), which characterizes trends in cancer rates over time, and the average annual percent changes (AAPCs), which describes the average APCs over a period of multiple years. Results were considered statistically significant at P < 0.05. Results: Between breast and gynecological cancers, breast cancer has the highest incidence rates among women in Asia. The time trend of the incidence rates showed a constant growth in breast, ovary and corpus uteri cancers. This rising trend was obviously sharper for uterine cancer (AAPC 95% CI = 3.4 [3.0, 3.7]) followed by breast [AAPC 95% CI = 2.1 (2.0, 2.2)] and ovarian cancers (AAPC 95% CI = 0.5 [-0.4, 1.3]). The age-adjusted incidence rate (ASR) of cervical cancer displayed a declining trend from 1998 to 2012 (AAPC 95% CI = -1.4 [-2.4, -0.5]). Conclusion: Incidence rates of breast and gynecological cancers have a rising trend in Asian countries. However, breast and gynecological cancers have different patterns of time trend.

show abstract

“…According to the GLOBOCAN 2012 findings, Lebanon had the highest incidence rates of all types of cancers in the Eastern Mediterranean Region (204.0 and 193.0 per 100,000 individuals in males and females, respectively) [ 16 ]. The differences between the countries, in terms of the incidence and burden of breast cancer, could be due to the different levels of exposure or the prevalence of risk factors in each country, implementation of screening programs, accessibility to the screening programs in different areas of a country, willingness of people to participate in these programs or improvements in the cancer registries [ 14 , 17 ]. Moreover, Lebanon has developed breast cancer screening guidelines for females over 40 years of age, which recommends annual mammography for those without a family history of breast cancer and annual screening 10 years before the age at which cancer was first diagnosed in those with a family history of breast cancer [ 18 ].…”

Section: Discussionmentioning

confidence: 99%

Burden of female breast cancer in the Middle East and North Africa region, 1990–2019

et al. 2022

View full text Add to dashboard Cite

Background There is no region-specific publication investigating the attributable burden of breast cancer, particularly among females. This article reported the burden of female breast cancer in the Middle East and North Africa (MENA) region, and its attributable risk factors between 1990 and 2019, by age, sex, and socio-demographic index (SDI). Methods Publicly available data on the incidence, death and disability-adjusted life years (DALY) were retrieved from the Global Burden of Disease (GBD) 2019 study for the 21 countries and territories in MENA, between 1990 and 2019, along with 95% uncertainty intervals (UIs). The relationship between the burden of female breast cancer, in terms of DALYs, and the SDI were also assessed using Smoothing Spline models. Results In 2019, the regional age-standardised incidence and death rates of female breast cancer were 37.5 and 15.2 per 100,000, which represent a 90.9 and 24.0% increase since 1990, respectively. In addition, in 2019 the regional age-standardised DALY rate was 472.7 per 100,000, which was 19.5% higher than in 1990. In 2019, the death rate increased steadily with advancing age, while the DALY rate increased steeply with age and reached its peak in the 70–74 age group. There was a positive association between SDI and the burden of breast cancer over the period 1990 to 2019. Moreover, in 2019 high fasting plasma glucose (6.9%) contributed to the largest proportion of attributable DALYs for female breast cancer in the MENA region. Conclusions There was a significant increase in the incidence rate of female breast cancer in MENA over the past three decades, although the death and DALY rates were both largely unchanged. Preventive programs targeting the major risk factors should be implemented in the region.

show abstract

Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis

Cited by 20 publications

References 54 publications

The Importance of Clinical Data for the Diagnosis of Breast Tumours in North Afghanistan

The Importance of Clinical Data for the Diagnosis of Breast Tumours in North Afghanistan

Trends in the Incidence Rates of Breast and Gynecological Cancers in Asia from 1998–2012: An Ecological Study

Burden of female breast cancer in the Middle East and North Africa region, 1990–2019

Contact Info

Product

Resources

About